The use of intermittent preventive treatment with sulfadoxine-pyrimethamine for preventing malaria in pregnant women

Clinical Infectious Diseases

Volumn 53, Issue 3, 2011, Pages 231-233

  Leke, Rose Gana Fomban ^a   Taylor, Diane Wallace ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PYRIMETHAMINE PLUS SULFADOXINE;

ADVERSE OUTCOME; ANEMIA; BED NET; DISEASE EXACERBATION; DISEASE TRANSMISSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG UTILIZATION; ERYTHROCYTE COUNT; FETUS DISEASE; FETUS RISK; HEALTH CARE POLICY; HEALTH SURVEY; HEMATOPOIESIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION RESISTANCE; INFECTION RISK; LOW BIRTH WEIGHT; MALARIA; MALARIA CONTROL; MALI; NONHUMAN; NOTE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REINFECTION; RISK REDUCTION; SEASONAL VARIATION; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; CHEMOPREVENTION; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA; MALE; PLASMODIUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; SULFADOXINE;

EID: 79960785049     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir383     Document Type: Note

References (5)

1. Technical Expert Group meeting on intermittent preventive treatment in pregnancy (IPTp). Geneva: WHO Headquarters; 11-13 July, 2007; Available at: whqlibdoc.who.int/publications/2008/97899241596640-eng.pdf.
2. Ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. A systematic review. JAMA 2007; 297:2603-16. (Pubitemid 46961032)
3. Maiga OM, Kayentao K, Traoré BT, et al. Superiority of three over two doses of intermittent preventive treatment with sulfadoxine- pyrimethamine for the prevention of malaria during pregnancy in Mali: a randomized controlled trial. Clin Infect Dis 2011; 53:215-223.
4. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis 2011; 53:224-230.
5. Harrington WE, Mutabingwa TK, Muehlenbachs A, et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A 2009; 106:9027-32.